ReP USP - Resultado da busca

Artigo de periodico
Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial (2017)
Rassi Júnior, Anis; Marin Neto, José Antonio; Rassi, Anis
Source: Memórias do Instituto Oswaldo Cruz. Unidade: FMRP
Subjects: MIOCARDIOPATIA CHAGÁSICA, DOENÇA CRÔNICA, RESULTADO DE TRATAMENTO, TRIPANOSSOMICIDAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RASSI JÚNIOR, Anis e MARIN NETO, José Antonio e RASSI, Anis. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial. Memórias do Instituto Oswaldo Cruz, v. 112, n. 3, p. 224-235, 2017Tradução . . Disponível em: https://doi.org/10.1590/0074-02760160334. Acesso em: 06 jun. 2024.
APA
Rassi Júnior, A., Marin Neto, J. A., & Rassi, A. (2017). Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial. Memórias do Instituto Oswaldo Cruz, 112( 3), 224-235. doi:10.1590/0074-02760160334
NLM
Rassi Júnior A, Marin Neto JA, Rassi A. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial [Internet]. Memórias do Instituto Oswaldo Cruz. 2017 ; 112( 3): 224-235.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1590/0074-02760160334
Vancouver
Rassi Júnior A, Marin Neto JA, Rassi A. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial [Internet]. Memórias do Instituto Oswaldo Cruz. 2017 ; 112( 3): 224-235.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1590/0074-02760160334
Artigo de periodico
Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification (2009)
Rassi Júnior, Anis; Rassi, Anis; Marin Neto, Jose Antonio
Source: Memórias do Instituto Oswaldo Cruz. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RASSI JÚNIOR, Anis e RASSI, Anis e MARIN NETO, Jose Antonio. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Memórias do Instituto Oswaldo Cruz, v. 104, p. 152-158, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762009000900021. Acesso em: 06 jun. 2024.
APA
Rassi Júnior, A., Rassi, A., & Marin Neto, J. A. (2009). Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Memórias do Instituto Oswaldo Cruz, 104, 152-158. doi:10.1590/s0074-02762009000900021
NLM
Rassi Júnior A, Rassi A, Marin Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 152-158.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1590/s0074-02762009000900021
Vancouver
Rassi Júnior A, Rassi A, Marin Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 152-158.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1590/s0074-02762009000900021
Artigo de periodico
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease (2009)
Marin Neto, Jose Antonio; Rassi Junior, Anis; Avezum Júnior, Álvaro; Mattos, Antonio C.; Rassi, Anis
Source: Memórias do Instituto Oswaldo Cruz. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN NETO, Jose Antonio et al. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz, v. 104, p. 319-324, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762009000900042. Acesso em: 06 jun. 2024.
APA
Marin Neto, J. A., Rassi Junior, A., Avezum Júnior, Á., Mattos, A. C., & Rassi, A. (2009). The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz, 104, 319-324. doi:10.1590/s0074-02762009000900042
NLM
Marin Neto JA, Rassi Junior A, Avezum Júnior Á, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 319-324.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1590/s0074-02762009000900042
Vancouver
Marin Neto JA, Rassi Junior A, Avezum Júnior Á, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 319-324.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1590/s0074-02762009000900042

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em